Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
Chemotherapy in gastric cancer & esophageal cancer - Basis, MAGIC trial, FLOT trial, CROSS protocol - YouTube
Is FLOT the only standard in the perioperative setting for gastric cancer? - YouTube
Presentazione di PowerPoint
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ...
JCM | Free Full-Text | Pattern of Recurrence and Patient Survival after Perioperative Chemotherapy with 5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) for Locally Advanced Esophagogastric Adenocarcinoma in Patients Treated Outside Clinical Trials
Safety and efficacy of neoadjuvant therapy in gastric cancer | CMAR
Multidisciplinary management of stage II-III gastric and gastro-oesophageal junction cancer - ScienceDirect
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer | British Journal of Cancer
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications
Scenario 1. FLOT, TAS-102, IOs Do They Improve the Lives of Patients With Gastric Cancer? - ppt download
Cancers | Free Full-Text | Beyond the Guidelines: The Grey Zones of the Management of Gastric Cancer. Consensus Statements from the Gastric Cancer Italian Network (GAIN)
Applied Sciences | Free Full-Text | Perioperative Chemotherapy with FLOT Scheme in Resectable Gastric Adenocarcinoma: A Preliminary Correlation between TRG and Radiomics
Frontiers | Towards Personalization in the Curative Treatment of Gastric Cancer
Gastrointestinal cancers: new standards of care from landmark trials | MDedge Hematology and Oncology
Peri-operative therapy for operable gastroesophageal adenocarcinoma: past, present and future - Annals of Oncology
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathologica
NEO- AND ADJUVANT TREATMENT FOR GASTRIC CANCER: THE ROLE OF CHEMOTHERAPY
Is FLOT the only standard in the preoperative setting for gastric cancer?
2038-Gastric and gastroesophageal neoadjuvant/adjuvant FLOT | eviQ
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications
KEYNOTE-585: Phase III study of perioperative chemotherapy with or without pembrolizumab for gastric cancer | Future Oncology
Trial diagram of the ESOPEC trial | Download Scientific Diagram
Treatment Switch in Poor Responders with Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy | SpringerLink
The RENAISSANCE (AIO-FLOT5) trial: effect of chemotherapy alone vs. chemotherapy followed by surgical resection on survival and quality of life in patients with limited-metastatic adenocarcinoma of the stomach or esophagogastric junction –
Efficacy and tolerability of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in unselected patients with advanced gastric and gastroesophageal cancer: does age really matter? | SpringerLink
